Hydrogel-based Drug Delivery System Market Analysis Report By Polymer Origin, By Route, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global hydrogel-based drug delivery system market was prized by USD 5.9 billion in 2020. It is estimated to witness a 7.5% CAGR from 2021 to 2028.

Hydrogel has three-dimensional polymeric networks, which can absorb large to small medicinal molecules such as peptides, NSAIDs, and proteins. Hence, they are broadly utilized in drug delivery functions. The eco-friendly and biocompatibility possessions, in addition to restricted discharge, create hydrogel as a prospective drug delivery arrangement. A big amount of revision, measuring the growth of the Covid-19 vaccine, using hydrogel, emphasizes the prospective use of hydrogel-based drug delivery systems.

Drivers

The advantages like restricted discharge, as well as targeted release together with the greater medicine inserting capability, are the various input factors, estimated to add to the expansion of the market for hydrogel-based drug delivery systems.

The easiness of manufacture and self-application quality is the most important cause, why hydrogel is a favored drug delivery service. On the other hand, the complication in manufacture hydrogel including the continuous exterior area might slow down the speed of the acceptance.

Rising asset plus the financial support by the main pharmaceutical products manufacturing companies in favor of R&D actions, meant for the searching of new-fangled diagnostic, medicine, as well as delivery systems, is single of the most important factors estimated to impel the hydrogel-based drug delivery system market, during the approaching years.

Due to its exceptional physical possessions, the hydrogel has been a hopeful drug delivery system. The rising R&D actions, connected with drug delivery systems, are expected to propel the market.

Restraints

The compatibility problem with a small number of medicines, excessive price of hydrogel, and low down mechanical power are the factors, anticipated to hamper the development of the market, in the extended period.

Polymer Origin Insight

The natural sector held the biggest, 32.3% revenue share and led the hydrogel-based drug delivery systems market, in 2020. The hydrogel can be categorized into three major forms hybrid, natural, and synthetic, based on polymer origin. In the making of natural hydrogel, proteins like collagen, gelatin, and lysosome, plus the polysaccharides like alginate, chitosan, and hyaluronic acid, are utilized. They contain superior cell bond possessions, however, owing to their mechanical as well as constancy matters, in recent times, are not as much chosen in creating drug delivery systems.

Due to their convenient degradation features, better mechanical possessions, improved life span, and superior medicine absorbing capability, hydrogel-based drug delivery systems are prepared of man-made polymer and are getting extra recognition than naturally resulting polymer. Poly (acrylic acid), Poly (vinyl pyrrolidone) starch, and Poly (vinyl pyrrolidone) are the extensively utilized artificial polymer in drug delivery function.

Synthetic as well as natural hydrogel are mixed to make hybrid hydrogel. The experience of hybrid polymerization is utilized in the making of a higher variety, described as a SMART hydrogel. These hydrogels are stimuli receptive and are dissimilar from usual hydrogels since the medicine discharge is reliant on chemical otherwise physical stimuli.

Delivery Route Insight

The ocular sector held the biggest, 38.5% revenue share, and led the hydrogel-based drug delivery system market, in 2020. Usually, the hydrogel is utilized in the applications of ocular medicine delivery, since the majority of the hard, as well as contact lenses, are prepared of hydrogel films. Hence, it happens to be simple to integrate the remedial medicines, into contact lenses.

The subcutaneous drug delivery sector is likely to observe a 9.3% CAGR, in the market, during the forecast period. Since hydrogel is an eco-friendly substance; they are widely utilized in the making of subcutaneous drug delivery systems. The implants naturally get decompose within the body, in this manner, the necessity for its surgical amputation is abolished.

The medicines are included in a hydrogel, intended for the restricted treatment of sicknesses in the buccal hollow space like stomatitis, periodontal disease, oral cancer, and fungal infection. The superior withholding and sticking together possessions of hydrogel, amid oral hollow space mucosa, assist in attaining restricted release of the medicine.

A hydrogel-based drug delivery system is utilized in the release of medicine in the oral hollow space. Rectal, Transdermal, and Vaginal are the additional drug delivery route sectors, estimated to observe a hopeful enlargement speed, during the forecast period.

Regional Insight

In 2020, North America held the biggest, 46.1% revenue share and led the global hydrogel-based drug delivery system market. The existence of local hydrogel suppliers and their recurrent product presentation, the continuation of a proficient repayment system, which includes the expenditure of contemporary treatments, are some input factors, expected to add to the expansion of the market, within the region.

The European Union declared financial support for 13 projects, in 2021. It includes the improvements of the hyaluronan sourced hydrogel system in mucosal drug deliverance. The plan is likely to begin in Oct 2021 and to go on for the time of three years. Such types of schemes are expected to get new-fangled hydrogel-based drug delivery systems, by this means boosting the enlargement of the market.

The market in the Asia Pacific is anticipated to go through the highest development percentage, during the forecast period. Increasing demand for enhanced medicinal treatment in various therapeutic fields, the existence of huge marked residents, growing demand to slash healthcare overheads, and getting better admittance to healthcare. These are some of the factors, expected to impel the enlargement of the market, during the forecast period. South Korea, China, and India are only some of the apparent markets, showing profitable development rates, within this section.

Companies

The major companies are participating in the actions like enlargement of the market to create additional sales as well as profit. The companies, operating in the market, are adopting policies like the presentation of new products, mergers & acquisitions, and joint ventures, to keep going in the extremely aggressive situation.

Some of the companies for the hydrogel-based drug delivery system market are:

    • Akorn, Incorporated
    • Ferring B.V.
    • Medtronic
    • Johnson & Johnson
    • GALDERMA
    • Tolmar Pharmaceuticals, Inc.
    • Endo International plc
    • Ocular Therapeutix, Inc.
    • Bausch and Lomb
    • Blairex Laboratories, Inc.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For this study, Million Insights has segmented the global hydrogel-based drug delivery system market report based on polymer origin, delivery route, and region:

• Polymer Origin Outlook (Revenue, USD Million, 2016 - 2028)
    • Natural
    • Synthetic
    • Hybrid

• Delivery Route Outlook (Revenue, USD Million, 2016 - 2028)
    • Subcutaneous
    • Ocular
    • Oral Cavity
    • Topical
    • Other

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
    • The Asia Pacific
        • China
        • Japan
        • India
        • Thailand
        • South Korea
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • UAE